EORTC Gynecological Cancer Group Spring Meeting 30-31 March 2023
Publié par Danko Janette le 30.03.2023
This two days Conference will provide an opportunity for EORTC members to highlight their accomplishments, identify gaps, and generate new ideas for implementing future practice-changing clinical trials in gynecological cancers.
Three outstanding keynote speakers will discuss the challenges and opportunities for immunotherapy and PARP inhibitors in gynecological cancers:
- Prof. José Conejo Garcia, Duke University, USA: “Novel interventions to render CAR T cells finally effective against gynecologic tumors”.
- Prof. George Coukos, Lausanne University Hospital, CH: “Mobilizing immunity against HGSOC (and why it has not worked so far)”.
- Prof. Inthidar Labidi-Galy, University of Geneva, CH: “Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis”.
More information and free registration are available at email@example.com
Conference chairman: Dr. Fernanda Herrera - CHUV-University of Lausanne
EORTC Chairman Gynecology Cancer Group